financial post
Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor
Financial Post • 7 MONTHS AGO
Ipsen delivers strong results in the first half of 2024, progresses on launches and upgrades its full-year guidance
Financial Post • 7 MONTHS AGO
Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases
Financial Post • 7 MONTHS AGO
PHASE III ARCADIA 1 and 2 Trial Primary Results Published in The Lancet: Galderma’s Nemolizumab Improves Key Aspects of Atopic Dermatitis – Itch, Skin Lesions and Sleep Disturbance
Financial Post • 7 MONTHS AGO
A neurological disorder stole her voice. Jennifer Wexton takes it back on the House floor.
Financial Post • 7 MONTHS AGO
A plan to replenish the Colorado River could mean dry alfalfa fields. And many farmers are for it
Financial Post • 7 MONTHS AGO
Publisher Jimmy Lai will testify in his defense at Hong Kong national security trial, lawyer says
Financial Post • 7 MONTHS AGO